Experimental Models of Brain Ischemia: A Review of Techniques, Magnetic Resonance Imaging, and Investigational Cell-Based Therapies
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stroke continues to be a significant cause of death and disability worldwide. Although major advances have been made in the past decades in prevention, treatment, and rehabilitation, enormous challenges remain in the way of translating new therapeutic approaches from bench to bedside. Thrombolysis, while routinely used for ischemic stroke, is only a viable option within a narrow time window. Recently, progress in stem cell biology has opened up avenues to therapeutic strategies aimed at supporting and replacing neural cells in infarcted areas. Realistic experimental animal models are crucial to understand the mechanisms of neuronal survival following ischemic brain injury and to develop therapeutic interventions. Current studies on experimental stroke therapies evaluate the efficiency of neuroprotective agents and cell-based approaches using primarily rodent models of permanent or transient focal cerebral ischemia. In parallel, advancements in imaging techniques permit better mapping of the spatial-temporal evolution of the lesioned cortex and its functional responses. This review provides a condensed conceptual review of the state of the art of this field, from models and magnetic resonance imaging techniques through to stem cell therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Differentiation of human adipose cells An alternative and plentiful source of adult MSCs is adipose tissue, which is accessible with a potential supply via liposuction procedures (134, 135).”
BackgroundReversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463 · cited 4×
“EXPERIMENTAL MODELS OF BRAIN ISCHEMIA WHICH MODELS ARE AVAILABLE? Human ischemic stroke usually results from middle cerebral artery (MCA) occlusion, and so techniques which occlude this artery are closest to the clinical picture (10, 11).”
BackgroundMethodInfluentialColman (2022) · doi:10.1073/pnas · Cited by 4,370
Neuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799 · cited 1×
“ENDOGENOUS NSCs In 2002, two research groups observed transient MCAo in the rat inducing expansion of neuroblasts from the ipsi-lateral subventricular zone (SVZ); unexpectedly, these cells migrated in chains to the ischemic penumbra (140, 141) rather than their customary destination, the olfactory bulb.”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Differentiation of human adipose cells An alternative and plentiful source of adult MSCs is adipose tissue, which is accessible with a potential supply via liposuction procedures (134, 135).”
BackgroundNudo, R. J., Wise, B. M., SiFuentes, F., & Milliken, G. W. (1996) · Science · doi:10.1126/science.272.5269.1791 · Cited by 1,911 · cited 1×
“On the other hand, primates more closely mirror both human pathophysiology of stroke and mechanisms of neural repair in several aspects including disease timeframe and cortical remapping of a brain also adapted for lateralization of function (69, 83).”
BackgroundMoseley, M. E., Cohen, Y., Mintorovitch, J., Chileuitt, L., Shimizu, H., Kucharczyk, J., Wendland, M. F., & Weinstein, P. R. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140218 · Cited by 1,644
Viability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370 · cited 1×
“Due to progressive metabolic failure the penumbra unavoidably evolves to necrosis without therapeutic intervention within a certain time window (87, 88).”
BackgroundExperimental studies of ischemic brain edema
Koizumi, J.-I., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986) · Nosotchu · doi:10.3995/jstroke.8.1 · Cited by 996
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
Sena, E. S., van der Worp, H. B., Bath, P. M. W., Howells, D. W., & Macleod, M. R. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000344 · Cited by 600 · cited 4×
“Interestingly, neither dosing nor timing of intervention was assessed as critical to functional improvement (9).”
BackgroundInfluentialNeurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Zhang, Z. G., & Chopp, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70061-4 · Cited by 596 · cited 5×
“Stem cell transplantation could be implemented weeks or months after injury, extending opportunities for therapeutic intervention (7, 130, 131).”
BackgroundInfluentialAnimal models of focal and global cerebral ischemia
Traystman, R. J. (2003) · ILAR Journal · doi:10.1093/ilar.44.2.85 · Cited by 413 · cited 1×
“In contrast to lissencephalic brains of mice and rats, those large species which, like humans, have gyrencephalic brains, may provide closer models of functional recovery (61, 62).”
BackgroundHowells, D. W., Porritt, M. J., Rewell, S. S., O'Collins, V., Sena, E. S., van der Worp, H. B., Traystman, R. J., & Macleod, M. R. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.66 · Cited by 309
Chen, J., Zacharek, A., Zhang, C., Jiang, H., Li, Y., Roberts, C., Lu, M., Kapke, A., & Chopp, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5071-04.2005 · Cited by 287
Macrae, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01398.x · Cited by 274 · cited 8×
“They recover more quickly than humans from neurological insult and harbor differences both in functional neuroanatomy, having a much lesser degree of lateralization of brain function, and structural neuronatomy, as outlined in Section “Larger Species” (48, 79).”
BackgroundMethodInfluentialMacrae, I. M., Robinson, M. J., Graham, D. I., Reid, J. L., & McCulloch, J. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.34 · Cited by 233
Clarkson, A. N., López-Valdés, H. E., Overman, J. J., Charles, A. C., Brennan, K., & Carmichael, S. T. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.7 · Cited by 103
Role of Nogo-A in neuronal survival in the reperfused ischemic brain
Kilic, E., ElAli, A., Kilic, Ü., Guo, Z., Ugur, M., Uslu, U., Bassetti, C. L., Schwab, M. E., & Hermann, D. M. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.268 · Cited by 79
Cited by
Dergunova, L. V., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Mozerov, S. A., Gubsky, L. V., & Limborska, S. A. (2018) · BMC Genomics · doi:10.1186/s12864-018-5039-5 · Cited by 70
Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29
Dergunova, L. V., Dmitrieva, V. G., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Sudarkina, O. Y., Gubsky, L. V., et al. (2021) · Molecular Biology · doi:10.1134/s0026893321010040 · Cited by 8
Metadata
- Authors
- Canazza, A., Minati, L., Boffano, C., Parati, E., & Binks, S.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 19-19
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2024578526
- Cited by
- 91
- References
- 18
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.